INR Innovative Properties Inc.

Nabis Holdings Completes the Purchase of Assets Including Established Extraction & Production Facility in Washington State

Nabis Holdings Completes the Purchase of Assets Including Established Extraction & Production Facility in Washington State

VANCOUVER, British Columbia, May 30, 2019 (GLOBE NEWSWIRE) -- Nabis Holdings Inc. formerly Innovative Properties (CSE:NAB) (OTC: INNPF) (FRA: 71P) (“Nabis” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has completed the previously announced purchase of certain assets from PDT Technologies LLC (“PDT”), including extraction and production equipment and rights to lease its current production facility in Port Townsend, WA. The purchase includes the exclusive licensing rights to Chong’s Choice brand products throughout the state of Washington.

Nabis is planning to spend approximately USD $3 million to further expand the existing production facility, which currently produces high grade cannabis concentrate. The expanded facility will include new highly specialized equipment, two new extraction lines, an extraction clean room and lab facility, capable of producing up to 20,500 KG of cannabis concentrate on an annual basis. The facility is expected to be subleased to a licensed Washington cannabis processor.

“We are thrilled to officially enter Washington State with the purchase of PDT’s certain assets. Washington represents the successful execution of another promising opportunity that will expand our production and licensing capabilities,” said Shay Shnet, CEO and Director of Nabis. “We remain committed to our aggressive expansion plans, as we evaluate other opportunities in limited license states that align with the Company’s multi-state cannabis expansion strategy.”

About Nabis Holdings Inc.

Nabis Holdings is a Canadian investment issuer that invests in high quality cash flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. Led by two of the co-founders of MPX Bioceutical, one of the largest takeovers in the U.S. Cannabis space to date, the company has a proven track record in emerging markets to create significant shareholder value. The Company is focused on investing across the entire vertically integrated aspects of the space with a focus on revenue generation, EBITDA and growth.

For more information, please visit

Forward-Looking Statements

All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The risks are without limitations: that the acquisitions will be completed by the Company or completed upon the terms disclosed; the price for cannabis and related products will remain consistent and the consumer demand remains strong; availability of financing to the Company to develop the retail locations; retention of key employees and management; changes in State and/or municipal regulations of retail operations and changes in government regulations generally. Important factors that could cause actual results to differ, materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission and the Alberta Securities Commission.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

For inquiries, please contact:

Investor Contact:

Allison Soss

KCSA Strategic Communications

PH: 212-896-1267

Company Contact:

Shay Shnet, CEO and Director

PH: 604-687-7130

EN
30/05/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Innovative Properties Inc.

 PRESS RELEASE

Nabis Holdings Commences Trading on the OTCQB® Venture Market in the ...

Nabis Holdings Commences Trading on the OTCQB® Venture Market in the U.S. Nabis Changes Fiscal Year-End to December 31 VANCOUVER, British Columbia, Nov. 13, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTCQB: NABIF) (FRA:A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that its common stock has been approved for trading on the OTCQB® Venture Market under the ticker symbol “NABIF,” effective as of the opening of trading today, November 13, 2019. The Company will continu...

 PRESS RELEASE

Nabis Holdings Closes Acquisition of Emerald Phoenix and Infusion Edib...

Nabis Holdings Closes Acquisition of Emerald Phoenix and Infusion Edibles in Arizona Closing of acquisition is non-dilutive as no Nabis common shares are issued VANCOUVER, British Columbia, Oct. 28, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA:A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has completed the acquisition of 100% of the membership units of Perpetual Healthcare Inc. This acquisition, previously announced on August 12, 2019 and Oc...

 PRESS RELEASE

Nabis Holdings Receives Regulatory Approval to Operate its New Assets,...

Nabis Holdings Receives Regulatory Approval to Operate its New Assets, Emerald Phoenix and Infusion Edibles in Arizona VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA:A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has received all required regulatory approvals to operate the assets of Perpetual Healthcare Inc, Emerald Phoenix, a licensed medical marijuana dispensary located in Phoenix, Arizona and Infusion Edi...

 PRESS RELEASE

Nabis Holdings Appoints Richard Dolan as Vice President of Investor Re...

Nabis Holdings Appoints Richard Dolan as Vice President of Investor Relations VANCOUVER, British Columbia, Oct. 03, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA: A2PL) (“NabisTM” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that it has appointed as Vice President of Investor Relations. Mr. Dolan joins Nabis bringing 27 years of experience within the wealth management realm. From building significant books of business personally to playing various and vital roles wi...

 PRESS RELEASE

Nabis Holdings Provides Shareholder Update and Reports Third Quarter 2...

Nabis Holdings Provides Shareholder Update and Reports Third Quarter 2019 Financial Results Strengthened management team with the appointment of Nicole Rusaw as Chief Financial Officer Cash and cash equivalents of CAD$20.3 million as of July 31, 2019 VANCOUVER, British Columbia, Oct. 02, 2019 (GLOBE NEWSWIRE) -- (CSE:NAB) (OTC: NABIF) (FRA: A2PL) (“Nabis™” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, reported its financial results for the third quarter ended July 31, 2019. All financial i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch